Form 4: Acadia Healthcare Director E. Perot Bissell Acquires 7,032 Shares Through Equity Grant

Acadia Healthcare Company, Inc. Director E. Perot Bissell acquired 7,032 shares of common stock on May 29, 2025, as part of a compensation grant with a three-year vesting schedule.

Summary

• E. Perot Bissell, a Director of Acadia Healthcare Company, Inc. (ACHC), acquired 7,032 shares of common stock.
• The transaction occurred on May 29, 2025, and was reported as an acquisition (Code A).
• The shares were acquired at a price of $0, indicating a grant, likely as part of director compensation.
• These acquired shares will vest over a three-year period in equal yearly installments, with the vesting commencing on May 29, 2026.
• Following this transaction, E. Perot Bissell directly beneficially owns a total of 45,655 shares of Acadia Healthcare common stock.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even if a grant, generally indicates alignment of interests and confidence in the company's future, which is a positive signal. It's a routine compensation event, so not extremely positive, but certainly not negative.

Positives

• The acquisition of shares by a director, even as a grant, aligns their financial interests with those of the shareholders, promoting long-term value creation.
• Equity compensation at a $0 price is a standard practice for director remuneration, which can aid in the retention of experienced board members.

Future Outlook

The acquired shares will vest over a three-year period in equal yearly installments, commencing on May 29, 2026.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation, which is a common practice across various industries, including healthcare, to incentivize and align management and board interests with company performance.

Corporate Governance

Related Party Transactions

• The acquisition of 7,032 shares of common stock by E. Perot Bissell, a director, from Acadia Healthcare Company, Inc. at a $0 price represents a related party transaction in the form of an equity compensation grant.

Stakeholder Impact

• Shareholders: The transaction aligns the director's interests with shareholders through increased equity ownership, potentially fostering a greater commitment to long-term company performance.

Next Steps

• The vesting of the 7,032 acquired shares will occur in equal yearly installments beginning May 29, 2026.

Key Dates

Recommendation

Keywords

Acadia Healthcare, ACHC, Form 4, Insider Transaction, Stock Acquisition, Director Compensation, Equity Grant, Beneficial Ownership